Cres Pharmaceuticals compound obtains orphan status for primary myelofibrosis Aug. 23, 2011 No Comments
Cell Therapeutics submits response to questions raised by EMA regarding pixantrone MAA Aug. 23, 2011 No Comments
EMA accepts for review submissions by Pfizer for two investigational anticancer therapies Aug. 22, 2011 No Comments
Interim phase II data presented on combination regimen including VX-222 in chronic hepatitis C July 28, 2011 No Comments
RSS